EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Emerging role of EZH2 in solid tumor metastasis

Ayushi Verma, Muqtada Ali Khan, Saumya Ranjan Satrusal, Dipak Datta

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2025-02 · 1880 (1) · 189253

DOI: 10.1016/j.bbcan.2024.189253 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2025-02. Verfasst von Ayushi Verma und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Biology, CSIR-Central Drug Research Institute (CDRI), Lucknow 226031, India. Hauptthemen laut MEDLINE: Enhancer of Zeste Homolog 2 Protein, Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Department of Science and Technology, Ministry of Science and Technology, India, University Grants Commission, CSIR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer cells experience multiple reversible changes during their metastatic spread. Epigenetic reprogramming, being reversible, has emerged as a critical driver of cancer metastasis. Epigenetic modulator Enhancer of Zeste homolog 2 (EZH2) is an important candidate for such reprogramming events. Both EZH2 protein and its catalytic function (H3K27me3) have been shown to promote solid tumor metastasis, although EZH2 functional inhibition has limited impact on primary tumor growth in some cancers. The dichotomous gene regulatory roles of EZH2 and H3K27me3 are currently being investigated to understand how they collectively contribute to promote metastasis. Here, we examine the multifaceted role of EZH2 in modulating solid tumor metastasis and its therapeutic potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Enhancer of Zeste Homolog 2 ProteinNeoplasmsHumansNeoplasm MetastasisEpigenesis, GeneticAnimalsGene Expression Regulation, NeoplasticHistones

Stichwörter der Autor:innen

Cancer therapyEZH2H3K27me3Metastasis

Substanzen

Enhancer of Zeste Homolog 2 ProteinEZH2 protein, humanHistones

Autor:innen und Institutionen

  • Division of Cancer Biology, CSIR-Central Drug Research Institute (CDRI), Lucknow 226031, India.
  • Division of Cancer Biology, CSIR-Central Drug Research Institute (CDRI), Lucknow 226031, India; Academy of Scientific and Innovative Research, Ghaziabad, Uttar Pradesh 201002, India.
  • Division of Cancer Biology, CSIR-Central Drug Research Institute (CDRI), Lucknow 226031, India; Academy of Scientific and Innovative Research, Ghaziabad, Uttar Pradesh 201002, India. Electronic address: dipak.datta@cdri…

Förderung

  • Department of Science and Technology, Ministry of Science and Technology, India
  • University Grants Commission
  • CSIR

Zitieren

APA

Verma, A., Khan, M. A., Satrusal, S. R., & Datta, D. (2025). Emerging role of EZH2 in solid tumor metastasis. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1880(1), 189253. https://doi.org/10.1016/j.bbcan.2024.189253

Vancouver

Verma A, Khan MA, Satrusal SR, Datta D. Emerging role of EZH2 in solid tumor metastasis. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2025;1880(1):189253. doi:10.1016/j.bbcan.2024.189253

BibTeX
@article{Verma2025,
  author = {Verma, Ayushi and Khan, Muqtada Ali and Satrusal, Saumya Ranjan and Datta, Dipak},
  title = {Emerging role of EZH2 in solid tumor metastasis},
  journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
  year = {2025},
  volume = {1880},
  number = {1},
  pages = {189253},
  doi = {10.1016/j.bbcan.2024.189253}
}
Kostenlos starten →